Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP237148.RArBUxFwL4i5tO83qoBv3j3vBRlwrld2iLPALmrPWEv9w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP237148.RArBUxFwL4i5tO83qoBv3j3vBRlwrld2iLPALmrPWEv9w130_assertion type Assertion NP237148.RArBUxFwL4i5tO83qoBv3j3vBRlwrld2iLPALmrPWEv9w130_head.
- NP237148.RArBUxFwL4i5tO83qoBv3j3vBRlwrld2iLPALmrPWEv9w130_assertion wasGeneratedBy ECO_0000203 NP237148.RArBUxFwL4i5tO83qoBv3j3vBRlwrld2iLPALmrPWEv9w130_provenance.
- NP237148.RArBUxFwL4i5tO83qoBv3j3vBRlwrld2iLPALmrPWEv9w130_assertion wasDerivedFrom befree-20140225 NP237148.RArBUxFwL4i5tO83qoBv3j3vBRlwrld2iLPALmrPWEv9w130_provenance.
- NP237148.RArBUxFwL4i5tO83qoBv3j3vBRlwrld2iLPALmrPWEv9w130_assertion SIO_000772 22434244 NP237148.RArBUxFwL4i5tO83qoBv3j3vBRlwrld2iLPALmrPWEv9w130_provenance.
- NP237148.RArBUxFwL4i5tO83qoBv3j3vBRlwrld2iLPALmrPWEv9w130_assertion evidence source_evidence_literature NP237148.RArBUxFwL4i5tO83qoBv3j3vBRlwrld2iLPALmrPWEv9w130_provenance.
- NP237148.RArBUxFwL4i5tO83qoBv3j3vBRlwrld2iLPALmrPWEv9w130_assertion description "[DNA testing, particularly for BRCA1 and BRCA2 in hereditary breast-ovarian cancer syndrome and p53 in the Li-Fraumeni syndrome, and many other syndromes is commercially available for inclusion in a cancer control program and merits attention in this major public health problem.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP237148.RArBUxFwL4i5tO83qoBv3j3vBRlwrld2iLPALmrPWEv9w130_provenance.